MHRA Recall Natzon 0.4 mg Sublingual Tablets Recalled

Home » News & Knowledge » MHRA Recall Natzon 0.4 mg Sublingual Tablets Recalled after Printing Mix Up

MHRA Recall Natzon 0.4 mg Sublingual Tablets Recalled after Printing Mix Up

The Medicines and Healthcare products Regulatory Agency (MHRA) are asking people to check their dispensed cartons of the opoid withdrawal drug Natzon 0.4 mg Sublingual Tablets from two batches 13D22 and 13D24. A carton printing error means that some pack may contain Buprenorphine 8 mg Sublingual Tablets in Natzon 0.4 mg cartons.

Batch number Expiry Date Pack Size First Distributed

13D22 April 2016 1 x 7 12 August 2013

13D24 April 2016 1 x 7 22 August 2013

There have been two reported cases of this so and it is thought a maximum of 300 packs may have been affected. Natzon 0.4 mg and Buprenorphone 8 mg are used to treat recovering drug addicts and help them with withdrawal.

News categories

Request a call back

Enquiry form

Email us

Service finder

Why Oakwood?

Here at Oakwood Solicitors, we’re not your average law firm – our team delivers a service which caters to you. From assessing your case through to completion, our staff have not only the knowledge and expertise, but also the compassion and understanding to put you at ease throughout the process.

Find out more